Intraoperative radiation therapy in the multimodality approach to hepatobiliary tract cancer

Charles Thomas, Hollis W. Merrick

Research output: Contribution to journalArticle

Abstract

IOERT is a reasonable option to consider in patients who have biliary tract cancers above AJCC or Bismuth stage I disease. Inherent resistance of biliary tract cancer cells to ionizing radiation would indicate that IOERT alone would not eradicate most of the tumor clonagen. EBRT (either preoperatively or postoperatively) should be used in combination with IOERT at experienced institutions that have access to both modalities. The single IOERT dose ranges are 10 to 20 Gy [55,67], whereas the EBRT dose ranges from 45 to 50 Gy in 25 to 28 fractions [67]. The most common energy level used is 8 MeV or less. In addition, IOERT port sizes of less than 6 cm in diameter, and often 4 cm or less, are recommended. Finally, intraoperative reconstruction of severely damaged blood vessels may decrease the clinical manifestation of radiation-induced injury to vessels [68].

Original languageEnglish (US)
Pages (from-to)979-992
Number of pages14
JournalSurgical Oncology Clinics of North America
Volume12
Issue number4
DOIs
StatePublished - Oct 2003
Externally publishedYes

Fingerprint

Biliary Tract Neoplasms
Radiotherapy
Radiation Injuries
Bismuth
Ionizing Radiation
Blood Vessels
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Intraoperative radiation therapy in the multimodality approach to hepatobiliary tract cancer. / Thomas, Charles; Merrick, Hollis W.

In: Surgical Oncology Clinics of North America, Vol. 12, No. 4, 10.2003, p. 979-992.

Research output: Contribution to journalArticle

@article{29d60eef41cb4ee28965dd45cd6c6d0b,
title = "Intraoperative radiation therapy in the multimodality approach to hepatobiliary tract cancer",
abstract = "IOERT is a reasonable option to consider in patients who have biliary tract cancers above AJCC or Bismuth stage I disease. Inherent resistance of biliary tract cancer cells to ionizing radiation would indicate that IOERT alone would not eradicate most of the tumor clonagen. EBRT (either preoperatively or postoperatively) should be used in combination with IOERT at experienced institutions that have access to both modalities. The single IOERT dose ranges are 10 to 20 Gy [55,67], whereas the EBRT dose ranges from 45 to 50 Gy in 25 to 28 fractions [67]. The most common energy level used is 8 MeV or less. In addition, IOERT port sizes of less than 6 cm in diameter, and often 4 cm or less, are recommended. Finally, intraoperative reconstruction of severely damaged blood vessels may decrease the clinical manifestation of radiation-induced injury to vessels [68].",
author = "Charles Thomas and Merrick, {Hollis W.}",
year = "2003",
month = "10",
doi = "10.1016/S1055-3207(03)00085-1",
language = "English (US)",
volume = "12",
pages = "979--992",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Intraoperative radiation therapy in the multimodality approach to hepatobiliary tract cancer

AU - Thomas, Charles

AU - Merrick, Hollis W.

PY - 2003/10

Y1 - 2003/10

N2 - IOERT is a reasonable option to consider in patients who have biliary tract cancers above AJCC or Bismuth stage I disease. Inherent resistance of biliary tract cancer cells to ionizing radiation would indicate that IOERT alone would not eradicate most of the tumor clonagen. EBRT (either preoperatively or postoperatively) should be used in combination with IOERT at experienced institutions that have access to both modalities. The single IOERT dose ranges are 10 to 20 Gy [55,67], whereas the EBRT dose ranges from 45 to 50 Gy in 25 to 28 fractions [67]. The most common energy level used is 8 MeV or less. In addition, IOERT port sizes of less than 6 cm in diameter, and often 4 cm or less, are recommended. Finally, intraoperative reconstruction of severely damaged blood vessels may decrease the clinical manifestation of radiation-induced injury to vessels [68].

AB - IOERT is a reasonable option to consider in patients who have biliary tract cancers above AJCC or Bismuth stage I disease. Inherent resistance of biliary tract cancer cells to ionizing radiation would indicate that IOERT alone would not eradicate most of the tumor clonagen. EBRT (either preoperatively or postoperatively) should be used in combination with IOERT at experienced institutions that have access to both modalities. The single IOERT dose ranges are 10 to 20 Gy [55,67], whereas the EBRT dose ranges from 45 to 50 Gy in 25 to 28 fractions [67]. The most common energy level used is 8 MeV or less. In addition, IOERT port sizes of less than 6 cm in diameter, and often 4 cm or less, are recommended. Finally, intraoperative reconstruction of severely damaged blood vessels may decrease the clinical manifestation of radiation-induced injury to vessels [68].

UR - http://www.scopus.com/inward/record.url?scp=0345017861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345017861&partnerID=8YFLogxK

U2 - 10.1016/S1055-3207(03)00085-1

DO - 10.1016/S1055-3207(03)00085-1

M3 - Article

C2 - 14989128

AN - SCOPUS:0345017861

VL - 12

SP - 979

EP - 992

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 4

ER -